Delarue C, Netchitailo P, Leboulenger F, Perroteau I, Escher E, Vaudry H
Gen Comp Endocrinol. 1984 Jun;54(3):333-8. doi: 10.1016/0016-6480(84)90144-8.
Somatostatin (SRIF), the somatotropin release inhibiting factor of the hypothalamus, has been reported to inhibit the production of angiotensin II (AII)-stimulated aldosterone in the rat adrenal glomerulosa cells. Since the interrenal of the frog is the homolog of mammalian adrenal zona glomerulosa, the effect of synthetic SRIF on perifused dice of Rana ridibunda was tested. Graded doses of SRIF did not modify the spontaneous production of corticosterone and aldosterone. The highest concentration of SRIF (10(-5) M) did not alter the stimulatory effect of the AII agonist [Sar1-Val5] AII upon corticosteroidogenesis. Thus, in apparent contradiction to recent findings in mammals, SRIF did not alter the effect of AII in the frog interrenal cell.
生长抑素(SRIF)是下丘脑的生长激素释放抑制因子,据报道它能抑制大鼠肾上腺球状带细胞中血管紧张素II(AII)刺激的醛固酮生成。由于青蛙的肾上腺是哺乳动物肾上腺球状带的同源物,因此测试了合成SRIF对牛蛙离体小块组织的作用。不同剂量的SRIF均未改变皮质酮和醛固酮的自发分泌。SRIF的最高浓度(10⁻⁵M)并未改变AII激动剂[Sar1-Val5]AII对皮质类固醇生成的刺激作用。因此,与最近在哺乳动物中的研究结果明显矛盾的是,SRIF并未改变AII对青蛙肾上腺细胞的作用。